MWG Biotech AG With Large Order For Oligonucleotides
10/19/2005 5:11:21 PM
The German biotech specialist MWG Biotech AG (FWB:NWU) announces the signature of a global supply contract for oligonucleotides (synthetic nucleic acids) with a large, international pharma company. MWG Biotech expects an annual turnover of approx. one million Euro to result from this supply agreement. The name of the pharma company as well as further details were not disclosed. MWG Biotech's Genomic Synthesis business unit (production of synthetic nucleic acids) had reported a total turnover of 19.7 million Euro at an EBITDA (earnings before taxes, interest and depreciation) of 3.4 million Euro in 2003.
comments powered by